marketing-medtech

**Country:** Denmark
**Founder:** Benedicte Grytte Dahl — Co-founder & CEO
**Background:** other | verified: False — Digital health executive / operator. Before co-founding Hemi Health (2024, Denmark), Benedicte Grytte Dahl spent ~4 years at Kry/Livi, serving as Country Manager for Kry Norway (and working on Vaccina). She holds an education from the Norwegian School of Economics (NHH). Her background is clearly digital-health business leadership/operations, not a generic "other" — so the claimed label is not supported.</actual_background>
<parameter name="evidence">Multiple independent real sources confirm her background. Sifted's "Kry founders factory" article describes her as "former Kry Norway country manager" who co-founded Hemi Health in 2024. Norwegian-language interview coverage (Abelia/LinkedIn) states she was country manager for Kry Norway, spending four years at Kry and working on Vaccina. TechSavvy's funding article describes her as "a digital health expert with 10+ years of experience from Kry," CEO and co-founder of Hemi Health. Her LinkedIn (no.linkedin.com/in/benedicte-grytte-dahl-26879930) lists her as Co-founder & CEO at Hemi Health with NHH (Norwegian School of Economics) education. None of these support a generic "other" classification; her background is specifically digital-health leadership.</evidence>
<parameter name="source">https://sifted.eu/articles/kry-founders-factory ; https://techsavvy.media/en/danish-healthtech-startup-scales-digital-treatment-model-with-multi-million-investment/ ; https://no.linkedin.com/in/benedicte-grytte-dahl-26879930
**Stage / fundraise:** Seed-stage, founded 2023 (genuinely early, ~30 months old). 1-10 / small team. Physical clinics in Frederiksberg, Middelfart and Aarhus plus a digital-first model; >1,000 patients treated in Denmark. / Raised EUR 4M seed Feb 2026 (led by EIFO + Swiss Health Ventures; existing investors Sondo Capital, Alliance VC, Crowberry); prior ~EUR 2.1M pre-seed. Funds earmarked for the AI platform; expanding to the Netherlands.
**Regulatory trigger:** Cross-border expansion into the Netherlands' insurance-driven system raises the bar on structured, auditable, outcome-oriented care pathways. The product is a proprietary digital platform doing structured diagnostics, personalized treatment plans and continuous monitoring with AI applied to "complex care" — features that trend toward Software-as-a-Medical-Device territory under EU MDR / IEC 62304 as algorithmic decision support deepens. No CE mark, MDR class, or reimbursement status was disclosed in available sources (left unstated rather than assumed), so the regulatory milestone is a forward-looking trigger as they scale the AI platform across borders.
**Email:** benedicte@hemihealth.com (confidence medium) — Not a published personal address. RocketReach reports Hemi Health uses a single email format, [first]@hemihealth.com, for 100% of work addresses, and lists the CEO's address as b******@hemihealth.com — consistent with benedicte@hemihealth.com. The verified domain is hemihealth.com (note: the candidate brief listed hemihealth.io, which did not resolve; the live/used domain is hemihealth.com, e.g. https://www.hemihealth.com/en). Published general inbox: hello@hemihealth.com.
**LinkedIn:** https://no.linkedin.com/in/benedicte-grytte-dahl-26879930 **Website:** https://www.hemihealth.com
**Score:** 10 -> Tier B
**Hook:** Congratulate on the EUR 4M seed (EIFO + Swiss Health Ventures) and the Netherlands launch. Angle for a CTO-led, small team that's just earmarked seed money for the AI platform: OmDev adds senior dev capacity (and a dedicated CTO who works alongside Mathias, not replacing him) at a fixed monthly price ~3x cheaper than hiring the in-house squad needed to ship the platform at expansion speed — and you keep the code. The differentiator for an insurance-driven NL market: as your AI decision-support deepens into SaMD territory, OmDev's pipeline produces compliance evidence by default (SOUP register signed each build + requirements-to-code-to-test traceability feeding an IEC 62304/MDR technical file), so the MDR paperwork is generated as you build rather than retrofitted before an audit.

---

## Founder & background
Benedicte Grytte Dahl is Co-founder & CEO — an operator/commercial founder, NOT finance/insurance/clinical/engineering. She was country manager (daglig leder) of Kry Norge, leading the digital-health scale-up's Norwegian arm through high growth and COVID, and features in Sifted's "Kry founders factory" of ex-Kry founders ([Sifted](https://sifted.eu/articles/kry-founders-factory); [LinkedIn](https://no.linkedin.com/in/benedicte-grytte-dahl-26879930)).
Correction to the brief: this is NOT a no-CTO company. Co-founder Mathias (Buch) Iversen is CTO with 20+ years in software engineering/product; Sune K-Holm Nielsen (ex-Kry UK) is CBDO; Anna Løfqvist heads Brand & Community ([The Org](https://theorg.com/org/hemi-health/org-chart/mathias-iversen); [The Hub](https://thehub.io/startups/hemi)).

## Funding & momentum
Founded 2023 — genuinely early. Raised EUR 4M seed in Feb 2026, led by Denmark's EIFO and Swiss Health Ventures, with Sondo Capital, Alliance VC and Crowberry following on; a prior ~EUR 2.1M pre-seed preceded it ([EU-Startups](https://www.eu-startups.com/2026/02/female-led-danish-healthtech-startup-hemi-health-raises-e4-million-to-expand-migraine-and-concussion-care-internationally/)).
A "significant chunk" is earmarked to further develop the proprietary AI-powered platform, and the company is expanding cross-border with the Netherlands as its first international market ([Menlo Times](https://www.menlotimes.com/post/how-hemi-health-is-scaling-digital-first-migraine-and-concussion-care-internationally)).

## Product & regulatory
Digital-first specialty clinic for migraine, headache, concussion and whiplash: physical clinics (Frederiksberg, Middelfart, Aarhus) + the HEMI app (video consults, symptom diary, care plans, continuous monitoring) on a proprietary, increasingly AI-driven platform that turns multi-year care journeys into structured programmes with measurable outcomes ([ArcticStartup](https://arcticstartup.com/hemi-health-raises-e4-million-seed/)).
No CE mark, MDR class or reimbursement status was disclosed in available sources, so these are left unstated. The regulatory trigger is forward-looking: scaling AI decision-support into the Netherlands' insurance-driven system, which "demands structured, outcome-oriented care pathways," pushes the product toward SaMD obligations under MDR / IEC 62304.

## Pain & buying signals
Small team scaling a proprietary AI platform across borders right after a raise — capacity and velocity pressure, with the CTO publicly betting on AI in "complex care." Insurance-driven NL market raises the documentation/auditability bar; as algorithmic decision-support deepens, MDR/IEC 62304 evidence burden grows on a thin team.

**Why OmDev fits**
Even with a strong technical co-founder, a post-seed team racing to ship an AI platform while opening a regulated foreign market needs senior dev throughput without building a full in-house squad. OmDev adds senior devs + a dedicated CTO who augments (not replaces) Mathias, at a fixed monthly price ~3x cheaper than hiring in-house, with the client owning the code. The clincher for an MDR/SaMD trajectory in the Dutch insurance market: OmDev's pipeline produces compliance evidence by default — a SOUP register signed each build plus requirements-to-code-to-test traceability feeding an IEC 62304/MDR technical file — so the regulatory paperwork is generated as you build (OmDev does not certify). References: CadSmile, SpeechLink.

---
**Sources:** https://www.eu-startups.com/2026/02/female-led-danish-healthtech-startup-hemi-health-raises-e4-million-to-expand-migraine-and-concussion-care-internationally/ · https://arcticstartup.com/hemi-health-raises-e4-million-seed/ · https://www.menlotimes.com/post/how-hemi-health-is-scaling-digital-first-migraine-and-concussion-care-internationally · https://thehub.io/startups/hemi · https://theorg.com/org/hemi-health/org-chart/mathias-iversen · https://sifted.eu/articles/kry-founders-factory · https://no.linkedin.com/in/benedicte-grytte-dahl-26879930 · https://www.hemihealth.com/en · https://rocketreach.co/hemi-health-email-format_b72f9907c457e7ed · https://www.mazanti.dk/en/news/hemi-health-raises-eur-4-million-in-seed-financing-round/